10.01.12
• A recent study conducted by researchers at Brigham and Women’s Hospital (BWH) found no causal link between the use of phthalates in personal care products and diabetes, according to Linda Loretz, PhD, director, safety and regulatory toxicology for the Personal Care Products Council in response to the Brigham and Women’s Hospital Study on Phthalates and Diabetes.
The study examined a possible association between diabetes and levels of certain phthalates in women.
“Diethyl phthalate, also known as DEP, is the only phthalate with significant use in cosmetics. The BWH study found no association between DEP and diabetes in any of the four models used by the study’s authors.
The US Food and Drug Administration (FDA) evaluated biomonitoring and toxicity data and concluded, “…FDA does not have compelling evidence that phthalates, as used in cosmetics, pose a safety risk.”
Moreover, DEP has been reviewed by other scientific authorities, including the Cosmetic Ingredient Review (CIR) Expert Panel in the US and the Scientific Committee on Consumer Safety (SCCS) in the EU, and found to be safe for use in cosmetics.
DEP is allowed for use throughout the world, added Loretz in her statement.
More info: www.cosmeticsinfo.org